Related Experiment Video

Updated: Aug 15, 2026

Application of Retinoic Acid to Obtain Osteocytes Cultures from Primary Mouse Osteoblasts
07:13

Application of Retinoic Acid to Obtain Osteocytes Cultures from Primary Mouse Osteoblasts

Published on: May 13, 2014

A retinoic acid receptor alpha antagonist selectively counteracts retinoic acid effects

C Apfel1, F Bauer, M Crettaz

  • 1Pharma Division, Preclinical Research, F. Hoffmann-La Roche, Basel, Switzerland.

Proceedings of the National Academy of Sciences of the United States of America
|August 1, 1992
PubMed

Insights

Researchers identified a novel synthetic retinoid that selectively blocks retinoic acid receptor alpha (RARα). This discovery aids in understanding RAR signaling pathways and their roles in cell differentiation and immune responses.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Immunology

Background:

  • Retinoic acid (RA) regulates crucial cellular processes like growth and differentiation by activating retinoic acid receptors (RARs).
  • Three RAR subtypes (RARα, RARβ, RARγ) exist, with distinct expression patterns suggesting specialized functions.
  • Understanding the specific roles of each RAR subtype is essential for deciphering RA's complex biological effects.

Purpose of the Study:

  • To identify and characterize a selective antagonist for RARα.
  • To investigate the functional consequences of RARα antagonism in cellular models.

Main Methods:

  • Synthesis and characterization of a novel synthetic retinoid.
  • Assay of the retinoid's antagonist activity against RARα.
  • Evaluation of the antagonist's effects on HL-60 cell differentiation and B-lymphocyte activation.

Main Results:

  • A synthetic retinoid was identified as a selective RARα antagonist.
  • This antagonist effectively counteracted RA-induced differentiation in HL-60 cells.
  • The antagonist also inhibited RA's effects on polyclonal B-lymphocyte activation.

Conclusions:

  • Selective RAR antagonists, like the one identified, are valuable tools for dissecting the RAR system.
  • These antagonists can help assign specific RA-regulated functions to individual RAR subtypes.
  • The findings have implications for understanding RA signaling in development, differentiation, and immunity.

More Related Videos

Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography05:03

Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography

Published on: December 27, 2024

Methodology for Studying Interactions of Vitamin A Membrane Receptors and Opsin Protein with their Ligands in Generating the Retinylidene Protein08:18

Methodology for Studying Interactions of Vitamin A Membrane Receptors and Opsin Protein with their Ligands in Generating the Retinylidene Protein

Published on: October 4, 2024

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers01:17

Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers

Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...